Clinical Trials Directory

Trials / Completed

CompletedNCT01270555

Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults

Efficacy Of Bupropion SR For Attention Deficit Hyperactivity Disorder (ADHD) In Adults With Recent Past or Current Substance Use Disorders

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The investigators propose to conduct an open study to evaluate the efficacy and tolerability of Bupropion SR using clinically relevant doses in ADHD adults with a recent history of or current substance use disorders. We hypothesize that Bupropion SR will be effective in treating ADHD in this population.

Conditions

Interventions

TypeNameDescription
DRUGBupropion SR100mg capsules Initial dosing 100mgSR every morning, to be titrated to 200mgSR twice daily maximum

Timeline

Start date
1999-05-01
Primary completion
2001-07-01
First posted
2011-01-05
Last updated
2013-03-08
Results posted
2011-02-25

Source: ClinicalTrials.gov record NCT01270555. Inclusion in this directory is not an endorsement.